nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—multiple sclerosis—amyotrophic lateral sclerosis	0.709	1	CtDrD
Mitoxantrone—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.206	1	CbGbCtD
Mitoxantrone—Fungal skin infection—Riluzole—amyotrophic lateral sclerosis	0.00252	0.0424	CcSEcCtD
Mitoxantrone—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00211	0.0356	CcSEcCtD
Mitoxantrone—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.0019	0.032	CcSEcCtD
Mitoxantrone—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0301	CcSEcCtD
Mitoxantrone—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00177	0.0298	CcSEcCtD
Mitoxantrone—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.00153	0.0257	CcSEcCtD
Mitoxantrone—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00149	0.025	CcSEcCtD
Mitoxantrone—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.022	CcSEcCtD
Mitoxantrone—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0215	CcSEcCtD
Mitoxantrone—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0215	CcSEcCtD
Mitoxantrone—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.0012	0.0202	CcSEcCtD
Mitoxantrone—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0187	CcSEcCtD
Mitoxantrone—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0187	CcSEcCtD
Mitoxantrone—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00095	0.016	CcSEcCtD
Mitoxantrone—SLC47A1—hindbrain—amyotrophic lateral sclerosis	0.000914	0.0668	CbGeAlD
Mitoxantrone—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.000912	0.0154	CcSEcCtD
Mitoxantrone—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.000886	0.0149	CcSEcCtD
Mitoxantrone—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.000841	0.0142	CcSEcCtD
Mitoxantrone—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.000788	0.0133	CcSEcCtD
Mitoxantrone—BTK—medulla oblongata—amyotrophic lateral sclerosis	0.000787	0.0575	CbGeAlD
Mitoxantrone—SLC47A2—nervous system—amyotrophic lateral sclerosis	0.000784	0.0573	CbGeAlD
Mitoxantrone—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000782	0.0132	CcSEcCtD
Mitoxantrone—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.000766	0.0129	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000763	0.0129	CcSEcCtD
Mitoxantrone—SLC47A2—central nervous system—amyotrophic lateral sclerosis	0.000755	0.0552	CbGeAlD
Mitoxantrone—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00071	0.012	CcSEcCtD
Mitoxantrone—BTK—spinal cord—amyotrophic lateral sclerosis	0.000702	0.0513	CbGeAlD
Mitoxantrone—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000694	0.0117	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000687	0.0116	CcSEcCtD
Mitoxantrone—PIM1—medulla oblongata—amyotrophic lateral sclerosis	0.000682	0.0498	CbGeAlD
Mitoxantrone—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000673	0.0113	CcSEcCtD
Mitoxantrone—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000626	0.0106	CcSEcCtD
Mitoxantrone—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000617	0.0104	CcSEcCtD
Mitoxantrone—PIM1—spinal cord—amyotrophic lateral sclerosis	0.000608	0.0444	CbGeAlD
Mitoxantrone—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000607	0.0102	CcSEcCtD
Mitoxantrone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.0006	0.0101	CcSEcCtD
Mitoxantrone—SLC47A2—brain—amyotrophic lateral sclerosis	0.000599	0.0438	CbGeAlD
Mitoxantrone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000597	0.0101	CcSEcCtD
Mitoxantrone—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000591	0.00997	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00058	0.00977	CcSEcCtD
Mitoxantrone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000576	0.00971	CcSEcCtD
Mitoxantrone—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.000573	0.00966	CcSEcCtD
Mitoxantrone—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000573	0.00966	CcSEcCtD
Mitoxantrone—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000572	0.00963	CcSEcCtD
Mitoxantrone—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000564	0.0095	CcSEcCtD
Mitoxantrone—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000561	0.00945	CcSEcCtD
Mitoxantrone—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000552	0.0093	CcSEcCtD
Mitoxantrone—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.000549	0.00925	CcSEcCtD
Mitoxantrone—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000537	0.00906	CcSEcCtD
Mitoxantrone—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000531	0.00894	CcSEcCtD
Mitoxantrone—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000529	0.00892	CcSEcCtD
Mitoxantrone—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000528	0.0089	CcSEcCtD
Mitoxantrone—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000528	0.0089	CcSEcCtD
Mitoxantrone—SLC47A1—brainstem—amyotrophic lateral sclerosis	0.000524	0.0383	CbGeAlD
Mitoxantrone—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000524	0.00883	CcSEcCtD
Mitoxantrone—PIM1—nervous system—amyotrophic lateral sclerosis	0.000512	0.0374	CbGeAlD
Mitoxantrone—PIM1—central nervous system—amyotrophic lateral sclerosis	0.000493	0.0361	CbGeAlD
Mitoxantrone—PIM1—cerebellum—amyotrophic lateral sclerosis	0.000482	0.0352	CbGeAlD
Mitoxantrone—Chills—Riluzole—amyotrophic lateral sclerosis	0.000474	0.00798	CcSEcCtD
Mitoxantrone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000472	0.00795	CcSEcCtD
Mitoxantrone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000466	0.00786	CcSEcCtD
Mitoxantrone—BTK—brain—amyotrophic lateral sclerosis	0.000452	0.033	CbGeAlD
Mitoxantrone—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00045	0.00758	CcSEcCtD
Mitoxantrone—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000444	0.00749	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000426	0.00718	CcSEcCtD
Mitoxantrone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000425	0.00716	CcSEcCtD
Mitoxantrone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000414	0.00698	CcSEcCtD
Mitoxantrone—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000411	0.00693	CcSEcCtD
Mitoxantrone—Cough—Riluzole—amyotrophic lateral sclerosis	0.000401	0.00676	CcSEcCtD
Mitoxantrone—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000398	0.00671	CcSEcCtD
Mitoxantrone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000397	0.00669	CcSEcCtD
Mitoxantrone—PIM1—brain—amyotrophic lateral sclerosis	0.000392	0.0286	CbGeAlD
Mitoxantrone—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000391	0.00659	CcSEcCtD
Mitoxantrone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000391	0.00659	CcSEcCtD
Mitoxantrone—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000391	0.00659	CcSEcCtD
Mitoxantrone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00039	0.00657	CcSEcCtD
Mitoxantrone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000387	0.00651	CcSEcCtD
Mitoxantrone—BTK—IL-5 Signaling Pathway—MAPT—amyotrophic lateral sclerosis	0.00038	0.0332	CbGpPWpGaD
Mitoxantrone—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000378	0.00637	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000375	0.00632	CcSEcCtD
Mitoxantrone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000375	0.00632	CcSEcCtD
Mitoxantrone—Infection—Riluzole—amyotrophic lateral sclerosis	0.000373	0.00628	CcSEcCtD
Mitoxantrone—Shock—Riluzole—amyotrophic lateral sclerosis	0.000369	0.00622	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000367	0.00619	CcSEcCtD
Mitoxantrone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000366	0.00617	CcSEcCtD
Mitoxantrone—SLC47A1—medulla oblongata—amyotrophic lateral sclerosis	0.000365	0.0267	CbGeAlD
Mitoxantrone—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000364	0.00614	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000363	0.00611	CcSEcCtD
Mitoxantrone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000357	0.00602	CcSEcCtD
Mitoxantrone—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000355	0.0311	CbGpPWpGaD
Mitoxantrone—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00035	0.00591	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000342	0.00576	CcSEcCtD
Mitoxantrone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000337	0.00567	CcSEcCtD
Mitoxantrone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00563	CcSEcCtD
Mitoxantrone—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000333	0.00562	CcSEcCtD
Mitoxantrone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00033	0.00556	CcSEcCtD
Mitoxantrone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000326	0.00549	CcSEcCtD
Mitoxantrone—SLC47A1—spinal cord—amyotrophic lateral sclerosis	0.000326	0.0238	CbGeAlD
Mitoxantrone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000323	0.00545	CcSEcCtD
Mitoxantrone—Pain—Riluzole—amyotrophic lateral sclerosis	0.000321	0.0054	CcSEcCtD
Mitoxantrone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000321	0.0054	CcSEcCtD
Mitoxantrone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000309	0.00521	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000307	0.00517	CcSEcCtD
Mitoxantrone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000298	0.00502	CcSEcCtD
Mitoxantrone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000296	0.005	CcSEcCtD
Mitoxantrone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000296	0.005	CcSEcCtD
Mitoxantrone—BTK—Kit receptor signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000278	0.0243	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000276	0.00466	CcSEcCtD
Mitoxantrone—SLC47A1—nervous system—amyotrophic lateral sclerosis	0.000274	0.0201	CbGeAlD
Mitoxantrone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000269	0.00453	CcSEcCtD
Mitoxantrone—SLC47A1—central nervous system—amyotrophic lateral sclerosis	0.000264	0.0193	CbGeAlD
Mitoxantrone—SLC47A1—cerebellum—amyotrophic lateral sclerosis	0.000258	0.0189	CbGeAlD
Mitoxantrone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000257	0.00432	CcSEcCtD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.000254	0.0222	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.000248	0.0217	CbGpPWpGaD
Mitoxantrone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000238	0.00402	CcSEcCtD
Mitoxantrone—Rash—Riluzole—amyotrophic lateral sclerosis	0.000236	0.00398	CcSEcCtD
Mitoxantrone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000236	0.00398	CcSEcCtD
Mitoxantrone—Headache—Riluzole—amyotrophic lateral sclerosis	0.000235	0.00396	CcSEcCtD
Mitoxantrone—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000229	0.02	CbGpPWpGaD
Mitoxantrone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000223	0.00375	CcSEcCtD
Mitoxantrone—SLC47A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000213	0.0186	CbGpPWpGaD
Mitoxantrone—SLC47A1—brain—amyotrophic lateral sclerosis	0.00021	0.0153	CbGeAlD
Mitoxantrone—CYP1B1—nervous system—amyotrophic lateral sclerosis	0.000201	0.0147	CbGeAlD
Mitoxantrone—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000199	0.0146	CbGeAlD
Mitoxantrone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—amyotrophic lateral sclerosis	0.000198	0.0173	CbGpPWpGaD
Mitoxantrone—CYP1B1—central nervous system—amyotrophic lateral sclerosis	0.000194	0.0142	CbGeAlD
Mitoxantrone—CYP1B1—cerebellum—amyotrophic lateral sclerosis	0.000189	0.0138	CbGeAlD
Mitoxantrone—SLC47A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000181	0.0158	CbGpPWpGaD
Mitoxantrone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000179	0.0156	CbGpPWpGaD
Mitoxantrone—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000178	0.013	CbGeAlD
Mitoxantrone—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000173	0.0126	CbGeAlD
Mitoxantrone—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.00017	0.0124	CbGeAlD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000168	0.0147	CbGpPWpGaD
Mitoxantrone—PIM1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000165	0.0144	CbGpPWpGaD
Mitoxantrone—SLC47A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000161	0.0141	CbGpPWpGaD
Mitoxantrone—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000154	0.0113	CbGeAlD
Mitoxantrone—ABCB1—embryo—amyotrophic lateral sclerosis	0.000154	0.0112	CbGeAlD
Mitoxantrone—BTK—Fc-epsilon receptor I signaling in mast cells—PLA2G4A—amyotrophic lateral sclerosis	0.000154	0.0134	CbGpPWpGaD
Mitoxantrone—CYP1B1—brain—amyotrophic lateral sclerosis	0.000154	0.0112	CbGeAlD
Mitoxantrone—CYP2E1—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.000148	0.013	CbGpPWpGaD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—ATF1—amyotrophic lateral sclerosis	0.000142	0.0124	CbGpPWpGaD
Mitoxantrone—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000141	0.0103	CbGeAlD
Mitoxantrone—ABCC1—brain—amyotrophic lateral sclerosis	0.000138	0.0101	CbGeAlD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000137	0.012	CbGpPWpGaD
Mitoxantrone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000135	0.0118	CbGpPWpGaD
Mitoxantrone—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00013	0.00948	CbGeAlD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000126	0.011	CbGpPWpGaD
Mitoxantrone—BTK—FAS (CD95) signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000126	0.011	CbGpPWpGaD
Mitoxantrone—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000125	0.00913	CbGeAlD
Mitoxantrone—PIM1—C-MYB transcription factor network—PTGS2—amyotrophic lateral sclerosis	0.000125	0.0109	CbGpPWpGaD
Mitoxantrone—BTK—Activated TLR4 signalling—ATF1—amyotrophic lateral sclerosis	0.000123	0.0107	CbGpPWpGaD
Mitoxantrone—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000122	0.00892	CbGeAlD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000117	0.0102	CbGpPWpGaD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—ATF1—amyotrophic lateral sclerosis	0.000115	0.0101	CbGpPWpGaD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—MMP9—amyotrophic lateral sclerosis	0.000115	0.01	CbGpPWpGaD
Mitoxantrone—ABCG2—brain—amyotrophic lateral sclerosis	0.000115	0.00837	CbGeAlD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000111	0.00968	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000108	0.00947	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000108	0.00947	CbGpPWpGaD
Mitoxantrone—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000104	0.00763	CbGeAlD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000104	0.0091	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000103	0.00899	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—ATF1—amyotrophic lateral sclerosis	0.000103	0.00898	CbGpPWpGaD
Mitoxantrone—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.0001	0.00735	CbGeAlD
Mitoxantrone—CYP1B1—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	9.99e-05	0.00873	CbGpPWpGaD
Mitoxantrone—ABCC1—S1P1 pathway—PTGS2—amyotrophic lateral sclerosis	9.92e-05	0.00868	CbGpPWpGaD
Mitoxantrone—CYP2E1—brain—amyotrophic lateral sclerosis	9.91e-05	0.00725	CbGeAlD
Mitoxantrone—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	9.83e-05	0.00719	CbGeAlD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.21e-05	0.00805	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.21e-05	0.00805	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—KIFAP3—amyotrophic lateral sclerosis	9.05e-05	0.00791	CbGpPWpGaD
Mitoxantrone—ABCB1—spinal cord—amyotrophic lateral sclerosis	8.77e-05	0.00641	CbGeAlD
Mitoxantrone—BTK—DAP12 signaling—CASP9—amyotrophic lateral sclerosis	8.67e-05	0.00758	CbGpPWpGaD
Mitoxantrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	8.3e-05	0.00725	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.21e-05	0.00717	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—CASP9—amyotrophic lateral sclerosis	8.15e-05	0.00713	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—CASP9—amyotrophic lateral sclerosis	8.15e-05	0.00713	CbGpPWpGaD
Mitoxantrone—ABCC1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.12e-05	0.0071	CbGpPWpGaD
Mitoxantrone—CYP1B1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.85e-05	0.00686	CbGpPWpGaD
Mitoxantrone—ABCC1—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	7.82e-05	0.00683	CbGpPWpGaD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—TP53—amyotrophic lateral sclerosis	7.79e-05	0.00681	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—CASP9—amyotrophic lateral sclerosis	7.55e-05	0.0066	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—ERBB4—amyotrophic lateral sclerosis	7.42e-05	0.00648	CbGpPWpGaD
Mitoxantrone—ABCB1—nervous system—amyotrophic lateral sclerosis	7.39e-05	0.0054	CbGeAlD
Mitoxantrone—ABCB1—central nervous system—amyotrophic lateral sclerosis	7.11e-05	0.0052	CbGeAlD
Mitoxantrone—CYP1B1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	7.11e-05	0.00621	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	7.07e-05	0.00618	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—ERBB4—amyotrophic lateral sclerosis	6.98e-05	0.0061	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—ERBB4—amyotrophic lateral sclerosis	6.98e-05	0.0061	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.98e-05	0.0061	CbGpPWpGaD
Mitoxantrone—ABCB1—cerebellum—amyotrophic lateral sclerosis	6.95e-05	0.00508	CbGeAlD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	6.86e-05	0.006	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	6.59e-05	0.00576	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—ERBB4—amyotrophic lateral sclerosis	6.46e-05	0.00565	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	6.46e-05	0.00564	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.93e-05	0.00519	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.93e-05	0.00519	CbGpPWpGaD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—TP53—amyotrophic lateral sclerosis	5.77e-05	0.00504	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.66e-05	0.00495	CbGpPWpGaD
Mitoxantrone—ABCB1—brain—amyotrophic lateral sclerosis	5.65e-05	0.00413	CbGeAlD
Mitoxantrone—BTK—Immune System—KIFAP3—amyotrophic lateral sclerosis	5.49e-05	0.0048	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.47e-05	0.00478	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	5.33e-05	0.00466	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.29e-05	0.00462	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.17e-05	0.00452	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5e-05	0.00437	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	4.99e-05	0.00436	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	4.98e-05	0.00435	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	4.98e-05	0.00435	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.81e-05	0.00421	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	4.73e-05	0.00414	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.65e-05	0.00407	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.64e-05	0.00406	CbGpPWpGaD
Mitoxantrone—ABCC1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.58e-05	0.004	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.52e-05	0.00395	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	4.45e-05	0.00389	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—OPTN—amyotrophic lateral sclerosis	4.45e-05	0.00389	CbGpPWpGaD
Mitoxantrone—CYP1B1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.43e-05	0.00387	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.37e-05	0.00382	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	4.32e-05	0.00378	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	4.23e-05	0.0037	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	4.2e-05	0.00368	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	4.15e-05	0.00363	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	4.08e-05	0.00356	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	4.01e-05	0.00351	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	3.78e-05	0.00331	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.73e-05	0.00326	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.59e-05	0.00314	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	3.39e-05	0.00296	CbGpPWpGaD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	3.34e-05	0.00292	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	3.33e-05	0.00291	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—ATF1—amyotrophic lateral sclerosis	3.33e-05	0.00291	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—DCTN1—amyotrophic lateral sclerosis	3.23e-05	0.00283	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.18e-05	0.00278	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CASP9—amyotrophic lateral sclerosis	3.17e-05	0.00277	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.14e-05	0.00274	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.1e-05	0.00271	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	3.04e-05	0.00266	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TPK1—amyotrophic lateral sclerosis	3.01e-05	0.00263	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3e-05	0.00262	CbGpPWpGaD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	2.94e-05	0.00257	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.73e-05	0.00239	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	2.71e-05	0.00237	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	2.68e-05	0.00234	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.63e-05	0.0023	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	2.6e-05	0.00228	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.54e-05	0.00222	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	2.53e-05	0.00221	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.52e-05	0.0022	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.52e-05	0.0022	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	2.45e-05	0.00214	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.44e-05	0.00213	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.44e-05	0.00213	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—VTA1—amyotrophic lateral sclerosis	2.4e-05	0.0021	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	2.37e-05	0.00207	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.35e-05	0.00205	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	2.33e-05	0.00204	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.31e-05	0.00202	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.3e-05	0.00201	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.27e-05	0.00199	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	2.26e-05	0.00198	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	2.26e-05	0.00197	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—C3—amyotrophic lateral sclerosis	2.25e-05	0.00197	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.23e-05	0.00195	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.23e-05	0.00195	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.23e-05	0.00195	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.22e-05	0.00194	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.22e-05	0.00194	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—C3—amyotrophic lateral sclerosis	2.16e-05	0.00189	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	2.15e-05	0.00188	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.14e-05	0.00187	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	2.13e-05	0.00186	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.1e-05	0.00184	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.08e-05	0.00182	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.07e-05	0.00181	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—SQSTM1—amyotrophic lateral sclerosis	2.07e-05	0.00181	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.05e-05	0.00179	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.03e-05	0.00177	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.01e-05	0.00176	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.99e-05	0.00174	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.97e-05	0.00172	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.97e-05	0.00172	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.95e-05	0.0017	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	1.94e-05	0.0017	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ATF1—amyotrophic lateral sclerosis	1.94e-05	0.00169	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.89e-05	0.00165	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CASP9—amyotrophic lateral sclerosis	1.85e-05	0.00161	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CHMP2B—amyotrophic lateral sclerosis	1.82e-05	0.00159	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—DAO—amyotrophic lateral sclerosis	1.82e-05	0.00159	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.78e-05	0.00156	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.77e-05	0.00155	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—DAO—amyotrophic lateral sclerosis	1.76e-05	0.00154	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.75e-05	0.00153	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PLB1—amyotrophic lateral sclerosis	1.65e-05	0.00144	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	1.64e-05	0.00144	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	1.6e-05	0.0014	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.59e-05	0.00139	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.59e-05	0.00139	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ERBB4—amyotrophic lateral sclerosis	1.58e-05	0.00138	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD40LG—amyotrophic lateral sclerosis	1.48e-05	0.0013	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—VCP—amyotrophic lateral sclerosis	1.47e-05	0.00128	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.46e-05	0.00127	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	1.4e-05	0.00123	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	1.38e-05	0.00121	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.38e-05	0.00121	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	1.37e-05	0.0012	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.35e-05	0.00118	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.35e-05	0.00118	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.34e-05	0.00117	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	1.32e-05	0.00116	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—C3—amyotrophic lateral sclerosis	1.31e-05	0.00115	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	1.29e-05	0.00113	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	1.27e-05	0.00111	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.27e-05	0.00111	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.25e-05	0.00109	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSR—amyotrophic lateral sclerosis	1.23e-05	0.00108	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.21e-05	0.00106	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.2e-05	0.00105	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.2e-05	0.00105	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.19e-05	0.00104	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.16e-05	0.00101	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	1.15e-05	0.00101	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000981	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	1.12e-05	0.00098	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.1e-05	0.000958	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.06e-05	0.000929	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.06e-05	0.000929	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	1.05e-05	0.000922	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.05e-05	0.000915	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.02e-05	0.000891	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.01e-05	0.000885	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.64e-06	0.000842	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	9.58e-06	0.000838	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.55e-06	0.000834	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.5e-06	0.000831	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.47e-06	0.000828	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.23e-06	0.000807	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	9.21e-06	0.000805	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	8.99e-06	0.000786	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.72e-06	0.000762	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	8.67e-06	0.000758	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	8.05e-06	0.000704	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	7.67e-06	0.00067	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	7.45e-06	0.000651	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	7.38e-06	0.000646	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	7.38e-06	0.000646	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	6.92e-06	0.000605	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.75e-06	0.00059	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.61e-06	0.000578	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	6.57e-06	0.000574	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	6.56e-06	0.000574	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.54e-06	0.000572	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.33e-06	0.000553	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.28e-06	0.000549	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	6.06e-06	0.00053	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.9e-06	0.000516	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.87e-06	0.000513	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—amyotrophic lateral sclerosis	5.83e-06	0.00051	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.62e-06	0.000492	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.44e-06	0.000475	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.34e-06	0.000467	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.17e-06	0.000452	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	5.08e-06	0.000444	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5e-06	0.000437	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.98e-06	0.000435	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.95e-06	0.000433	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.55e-06	0.000397	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.44e-06	0.000388	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	4.25e-06	0.000372	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOE—amyotrophic lateral sclerosis	4.11e-06	0.000359	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.05e-06	0.000354	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	3.74e-06	0.000327	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.73e-06	0.000326	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.55e-06	0.000311	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	3.48e-06	0.000304	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.26e-06	0.000285	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.07e-06	0.000268	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.91e-06	0.000255	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.82e-06	0.000246	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	2.69e-06	0.000235	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.67e-06	0.000234	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.56e-06	0.000224	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.46e-06	0.000215	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.02e-06	0.000177	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.84e-06	0.000161	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.65e-06	0.000144	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.51e-06	0.000132	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.39e-06	0.000121	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.25e-06	0.000109	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.54e-07	7.46e-05	CbGpPWpGaD
